Clinical Trial Update: Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating SIMBRINZA suspension as add-on therapy to a prostaglandin analogue in ocular hypertension and open-angle glaucoma; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Alcon Research | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 4 | Status: COMPLETED | Results posted: 2015-06-08